Burden of Illness
Health-Related Quality of Life
Healthcare Resource Utilization
Patient Reported Outcomes
This retrospective study of community oncology patients with breast cancer gene (BRCA)-mutated metastatic breast cancer (MBC) examined treatment outcomes and health resource utilization (HRU) and...
A retrospective analysis of medical records of US community oncology practices was conducted to assess healthcare costs during treatment with epidermal growth factor receptor (EGFR) tyrosine kinase...
Treatment options for advanced non-squamous non-small cell lung cancer (NSCLC) in the first line include platinum-based doublet therapy with or without bevacizumab. This study examined efficacy...
Retrospective analysis of patient-reported symptoms with the 38-item Patient Care Monitor survey, collected in routine clinical care for 1138 patients with non-small cell lung cancer at eight US...
This study examined the real-world effectiveness of fulvestrant monotherapy as first (L1) or second line (L2) treatment after metastatic breast cancer (MBC) diagnosis. The results showed that first...
The purpose of this study was to provide an understanding of the effectiveness of existing therapies in patients with advanced head and neck cancer (HNC), particularly in clinical practice. Data from...